EvergreenHealth

Kirkland, Washington 98034

7 studies enrolling now · 20 studies all time

What they study most

Alzheimer's Disease Dementia, Amyloid, Biofilm Formation, Cognitive Dysfunction, Degenerative Disc Disease, Dementia With Lewy Bodies, Early Parkinson Disease, Early Parkinson Disease (Early PD), Erythema, Essential Tremor, Idiopathic Parkinson Disease, Influenza, Human

Studies at this site

• A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7) — Recruiting now
• A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease — Recruiting now
• Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis — Recruiting now
• Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry — Recruiting now
• Parkinson's Foundation PD GENEration Genetic Registry — Recruiting now
• Phase 3, Open Label Extension Study of ACP-204 in Lewy Body Dementia Psychosis — Enrolling by invitation
• A Study to Learn About the Safety of Diranersen (BIIB080) Injections and Whether They Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of Age — Running, not enrolling
• A Phase 2 Study of ONO-2808 in Patients With Multiple System Atrophy — Running, not enrolling
• Advanced Materials Science in XLIF Study — Enrolling by invitation
• PROSEEK: A Phase 2 Study In Early Parkinson's Disease Patients Evaluating The Safety And Efficacy Of Abl Tyrosine Kinase Inhibition Using K0706 — Stopped early
• A Study to Evaluate a Modified RNA Vaccine Against Influenza in Adults 18 Years of Age or Older — Completed
• Randomized Study of Silq Urinary Catheter — Completed
• Synuclein-One Study — Completed
• Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's Disease — Completed
• A Non-interventional Study for the Collection of Biospecimens From Patients With Parkinson's Disease — Stopped early
• A Pilot Study of Warm and Cold Compress to Reduce Injection Site Erythema Due to Peginterferon-beta-1a in MS — Completed
• Investigating Central Mechanisms of Overactive Bladder in Adults With Parkinson's Disease — Completed
• Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis (MS) — Completed
• Efficacy, Safety and Tolerability Study of APL-130277 for the Acute Treatment of OFF Episodes in Patients With Parkinson's Disease — Completed
• A Pilot Study of the Cala ONE Device for Essential Tremor — Completed